Wuyun Su

First-in-human phase I/Ib study of QL1706 (PSB205), a bifunctional PD1/CTLA4 dual blocker, in patients with advanced solid tumors

Yuanyuan Zhao, Yuxiang Ma, Aimin Zang et al. · Journal of Hematology & Oncology · 2023 · 41 citations · Full text

A multiple center, open-label, single-arm, phase II clinical trial of MRG002, an HER2-targeted antibody-drug conjugate, in patients with HER2-low expressing advanced or metastatic breast cancer.

Zefei Jiang, Tao Sun, Xiaojia Wang et al. · Journal of Clinical Oncology · 2022 · 36 citations

Breast Oncology, Immunology, Pathology +16

Treatment Patterns and Outcomes in Chinese Patients with Gastric Cancer by <scp>HER2</scp> Status: A Noninterventional Registry Study (<scp>EVIDENCE</scp>)

Shukui Qin, Jiafu Ji, Rui‐Hua Xu et al. · The Oncologist · 2021 · 30 citations · Full text

miR-655-3p inhibits cell migration and invasion by targeting pituitary tumor-transforming 1 in non-small cell lung cancer

Wei Wang, Ranhua Cao, Wuyun Su et al. · Bioscience Biotechnology and Biochemistry · 2019 · 27 citations · Full text

Routine-Dose and High-Dose Icotinib in Patients with Advanced Non–Small Cell Lung Cancer Harboring EGFR Exon 21-L858R Mutation: the Randomized, Phase II, INCREASE Trial

Xi Li, Li Zhang, Da Jiang et al. · Clinical Cancer Research · 2020 · 26 citations · Full text